Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.45 |
| ▸ | HPGD | P15428 | 2/20 | 0.45 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.42 |
| ▸ | NPC1 | O15118 | 3/20 | 0.41 |
| ▸ | RAB9A | P51151 | 3/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.41 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.41 |
| ▸ | RELA | Q04206 | 1/20 | 0.41 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.41 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.41 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.41 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10378958 | 0.88 | ALDH1A1 (0.42) | ALDH1A1HPGDTAAR1SMN1; SMN2ALOX15 | |
| SCHEMBL971269 | 0.84 | ALDH1A1 (0.47) | ALDH1A1HPGDTAAR1SMN1; SMN2ALOX15 | |
| SCHEMBL9249990 | 0.83 | ALDH1A1 (0.43) | ALDH1A1HPGDTAAR1SMN1; SMN2ALOX15 | |
| SCHEMBL22607754 | 0.83 | ALDH1A1 (0.46) | ALDH1A1HPGDTAAR1SMN1; SMN2ALOX15 | |
| SCHEMBL10569720 | 0.83 | ALDH1A1 (0.46) | ALDH1A1HPGDTAAR1SMN1; SMN2ALOX15 | |
| SCHEMBL4290928 | 0.83 | ALDH1A1 (0.46) | ALDH1A1HPGDTAAR1SMN1; SMN2ALOX15 | |
| SCHEMBL2901854 | 0.83 | ALDH1A1 (0.43) | ALDH1A1HPGDTAAR1SMN1; SMN2ALOX15 | |
| SCHEMBL22607753 | 0.83 | ALDH1A1 (0.46) | ALDH1A1HPGDTAAR1SMN1; SMN2ALOX15 | |
| SCHEMBL10568010 | 0.83 | ALDH1A1 (0.46) | ALDH1A1HPGDTAAR1SMN1; SMN2ALOX15 | |
| SCHEMBL10568015 | 0.83 | ALDH1A1 (0.46) | ALDH1A1HPGDTAAR1SMN1; SMN2ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025231514-A1 | ANTIVIRAL FORMULATIONS | Vapour Science (AU) | 2025-11-13 | — | — | WO | disclosed |
| CN-102336636-A | Method for synthesizing alkyl-substituted cyclohexenyl alpha, beta-saturated ketones | SHANGHAI AIPU VEGETABLE TECHNOLOGY CO LTD | 2012-02-01 | — | — | CN | disclosed |
| EP-1233959-B1 | HETEROCYCLO-ALKYLSULFONYL PYRAZOLE DERIVATIVES AS ANTI-INFLAMMATORY/ANALGESIC AGENTS | PFIZER PROD INC (US) | 2005-03-16 | — | — | EP | disclosed |
| US-20030236258-A1 | Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents | PFIZER INC. | 2003-12-25 | — | — | US | disclosed |
| US-6531492-B1 | Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents | PFIZER INC. | 2003-03-11 | — | — | US | disclosed |
| EP-1233959-A1 | HETEROCYCLO-ALKYLSULFONYL PYRAZOLE DERIVATIVES AS ANTI-INFLAMMATORY/ANALGESIC AGENTS | Pfizer Products Inc. (US) | 2002-08-28 | — | — | EP | disclosed |
| WO-2001040216-A1 | HETEROCYCLO-ALKYLSULFONYL PYRAZOLE DERIVATIVES AS ANTI-INFLAMMATORY/ANALGESIC AGENTS | PFIZER PRODUCTS INC. (US) | 2001-06-07 | — | — | WO | disclosed |
| US-3966822-A | DECARBOXYLATION CATALYSTS, ZIRCONIUM OXIDE, ALKALI OR ALKALINE EARTH METAL OXIDES | CHISSO CORPORATION (JA) | 1976-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030236258-A1 | Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents | PTGS1, SULT2A1, PTGES3 | ALDH1A1 211/4885HPGD 356/4885TAAR1 978/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.